A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Di-Isonicotinoyl Triazole - Request Quote

Picture of Di-Isonicotinoyl Triazole

Di-Isonicotinoyl Triazole

SZ CAT No:SZ-I001034
CAS No
NA
Mol.F.
C14H9N5O2
Mol.Wt.
279.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Di-Isonicotinoyl Triazole is chemically (1H-1,2,3-Triazole-4,5-diyl)bis(pyridin-4-ylmethanone). Di-Isonicotinoyl Triazole is supplied with detailed characterization data compliant with regulatory guideline. Di-Isonicotinoyl Triazole can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Isoniazid.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Di-Isonicotinoyl Triazole

Purchase Di-Isonicotinoyl Triazole

Di-Isonicotinoyl Triazole suppliers

Di-Isonicotinoyl Triazole manufacturers

Di-Isonicotinoyl Triazole price

Order Di-Isonicotinoyl Triazole

Enquire Di-Isonicotinoyl Triazole

Di-Isonicotinoyl Triazole cost

Di-Isonicotinoyl Triazole Supplier

Di-Isonicotinoyl Triazole Distributor

Di-Isonicotinoyl Triazole for Method Validation

Isoniazid Reference Standard

Di-Isonicotinoyl Triazole for ANDA Filing

Di-Isonicotinoyl Triazole for Forced Degradation Studies

Di-Isonicotinoyl Triazole Identification Standards

Di-Isonicotinoyl Triazole for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,